CL2004000751A1 - PHARMACEUTICAL COMBINATION CONTAINING (A) ELETRIPAN, OR ONE OF ITS SALTS, AND (B) SODIUM BICARBONATE; COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING SUCH COMBINATION; AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR TREATMENT AND PREV - Google Patents

PHARMACEUTICAL COMBINATION CONTAINING (A) ELETRIPAN, OR ONE OF ITS SALTS, AND (B) SODIUM BICARBONATE; COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING SUCH COMBINATION; AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR TREATMENT AND PREV

Info

Publication number
CL2004000751A1
CL2004000751A1 CL2004000751A CL2004000751A CL2004000751A1 CL 2004000751 A1 CL2004000751 A1 CL 2004000751A1 CL 2004000751 A CL2004000751 A CL 2004000751A CL 2004000751 A CL2004000751 A CL 2004000751A CL 2004000751 A1 CL2004000751 A1 CL 2004000751A1
Authority
CL
Chile
Prior art keywords
combination
pharmaceutical
treatment
sodium bicarbonate
eletripan
Prior art date
Application number
CL2004000751A
Other languages
Spanish (es)
Inventor
John Humphrey Michael
Original Assignee
Pfizer Inc Sa Organizada Bajo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc Sa Organizada Bajo filed Critical Pfizer Inc Sa Organizada Bajo
Publication of CL2004000751A1 publication Critical patent/CL2004000751A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMBINACION ELETRIPTAN, O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES, Y BICARBONATO DE SODIO. LA COMBINACION PROPORCIONA UNA ABSORCION RAPIDA DE ELETRIPTAN CUANDO SE TOMA POR VIA ORAL. LA COMBINACION ES UTIL PARA EL TRATAMIENTO O LA PREVENCION DE UNA ENFERMEDAD PARA LA QUE ES INDICADO UN AGENTE AGONISTA DED 5-HT1, PARTICULARMENTE EN EL TRATAMIENTO DE UNA MIGRANA O PARA LA PREVENCION DE UNA RECURRENCIA DE MIGRANA.ELETRIPTAN COMBINATION, OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS, AND SODIUM BICARBONATE. THE COMBINATION PROVIDES A FAST ABSORPTION OF ELETRIPTAN WHEN IT IS TAKEN BY ORAL. THE COMBINATION IS USEFUL FOR THE TREATMENT OR PREVENTION OF AN ILLNESS FOR WHICH A DED 5-HT1 AGONIST AGENT IS INDICATED, PARTICULARLY IN THE TREATMENT OF A MIGRANE OR FOR THE PREVENTION OF A MIGRANE RECURRENCE.

CL2004000751A 2003-04-11 2004-04-07 PHARMACEUTICAL COMBINATION CONTAINING (A) ELETRIPAN, OR ONE OF ITS SALTS, AND (B) SODIUM BICARBONATE; COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING SUCH COMBINATION; AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR TREATMENT AND PREV CL2004000751A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0308469A GB0308469D0 (en) 2003-04-11 2003-04-11 Pharmaceutical combination

Publications (1)

Publication Number Publication Date
CL2004000751A1 true CL2004000751A1 (en) 2005-02-25

Family

ID=9956666

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2004000751A CL2004000751A1 (en) 2003-04-11 2004-04-07 PHARMACEUTICAL COMBINATION CONTAINING (A) ELETRIPAN, OR ONE OF ITS SALTS, AND (B) SODIUM BICARBONATE; COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING SUCH COMBINATION; AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR TREATMENT AND PREV

Country Status (3)

Country Link
CL (1) CL2004000751A1 (en)
GB (1) GB0308469D0 (en)
GT (1) GT200400060A (en)

Also Published As

Publication number Publication date
GT200400060A (en) 2004-12-23
GB0308469D0 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
CL2004000643A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A 5-HT 1B / 1D AGONIST AND A SELECTIVE CYCLLOXYGENASA-2 INHIBITOR, USEFUL IN THE TREATMENT OF MIGRANE.
BRPI0408396A (en) orally consumable, rapidly dissolving films containing pharmaceutically active agents
CY1111458T1 (en) DOSAGE FORMS OF GENERAL LINEAR, ANAVARASUS, ORAL FENTANYL AND METHODS OF ADMINISTRATION
AR062860A1 (en) THERAPEUTIC COMBINATIONS 482
NO20062504L (en) Compositions and dosage forms for improved absorption
ATE493973T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN
EA200901393A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE
DK1185253T3 (en) Oral preparation for administration of a solid combination of tramadol and diclofenac
MXPA05007609A (en) CaSR ANTAGONIST.
RS50768B (en) Dosage regimen and pharmaceutical composition for emergency contraception
ES2190205T3 (en) COMBINATION FOR THE TREATMENT OF THE ALCOHOL DEPENDENCE CONTAINING AN OPIOID ANTAGONIST AND A NMDA RECEPTOR COMPLEX MODULATOR.
ATE287264T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
ATE499939T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN POLYMORPHO A
DE602004005564D1 (en) Pharmaceutical composition for thrombin peptide derivatives
WO2005007137A3 (en) Tablets containing ambroxol
CO5580741A2 (en) PHARMACEUTICAL COMPOSITION INCLUDING A 5HT1 RECEIVER AGONIST
AR026254A1 (en) THE USE OF A CONTROLLED RELEASE PREPARATION FOR THE PREPARATION OF A MEDICINAL PRODUCT TO INCREASE THE DOSE OR SYSTEM EXPOSURE OF A PHARMACO THAT INHIBITS PHOSPHODESTERASE 4
AR038858A1 (en) COMBINATION
UY26171A1 (en) PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF LATE APPEARANCE DYSKINESIA
CL2004000751A1 (en) PHARMACEUTICAL COMBINATION CONTAINING (A) ELETRIPAN, OR ONE OF ITS SALTS, AND (B) SODIUM BICARBONATE; COMPOSITION AND PHARMACEUTICAL PRODUCT CONTAINING SUCH COMBINATION; AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR TREATMENT AND PREV
EA200702386A1 (en) SOLID PHARMACEUTICAL COMPOSITION FOR LONG-TERM EXEMPTION OF 1- (2,3,4-TRIMETOXIBENZYL) PIPERAZINE AND METHOD FOR ITS PREPARATION
AR044009A1 (en) PHARMACEUTICAL COMBINATION INCLUDING ELETRIPTAN AND SODIUM BICARBONATE
AR033807A1 (en) USE OF (R) - (-) - 2- [5- (4-FLUOROPHENYL) -3-PIRIDYLMETHYLAMINOME] -CROMANO AND ITS ACCEPTABLE SALTS FOR PHYSIOLOGICAL USE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION
EP1064967A3 (en) 5HT1 receptor agonists, caffeine and either a COX-2 inhibitor or NSAID for the treatment of migraine